Sestrin 3 gene regulates convulsions in epilepsy
Epilepsy has a strong genetic component and susceptibility to the disease is influenced by hundreds of genes. Now, researchers have used a ‘systems genetics’ approach to determine how these genes work together to cause epilepsy.
The team analysed hippocampal brain tissue samples from 129 people with temporal lobe epilepsy and found that genetic control of convulsions was due to a single gene, Sestrin 3 (SESN3). Furthermore, in a zebrafish model of epilepsy, knockdown of this gene led to attenuated seizures and reduced expression of proconvulsive molecules.
The study provides the first evidence of a function for SESN3 in disorders of the human brain and offers hope that disease-modifying therapies can be developed for epilepsy, write the researchers in Nature Communications.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067753
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00Buy now